These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10197493)

  • 41. Long-term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding.
    Chen J; Zeng XQ; Ma LL; Huang XQ; Tseng YJ; Wang J; Luo TC; Chen SY
    J Dig Dis; 2016 Apr; 17(4):252-9. PubMed ID: 26896761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of portosystemic collaterals by SPECT imaging after endoscopic variceal sclerotherapy: usefulness for predicting recurrence.
    Azuma M; Kashiwagi T; Nagasawa M; Ito Y; Naito M; Ishibashi K; Katayama K
    J Nucl Med; 2000 Apr; 41(4):600-4. PubMed ID: 10768559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic sclerotherapy of oesophageal varices. A clinical study.
    Söderlund C
    Acta Chir Scand Suppl; 1985; 524():1-86. PubMed ID: 3893006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.
    Avgerinos A; Armonis A; Manolakopoulos S; Poulianos G; Rekoumis G; Sgourou A; Gouma P; Raptis S
    J Hepatol; 1997 May; 26(5):1034-41. PubMed ID: 9186834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sclerotherapy for gastric fundal variceal bleeding: is complete obliteration possible without cyanoacrylate?
    Kojima K; Imazu H; Matsumura M; Honda Y; Umemoto N; Moriyasu H; Orihashi T; Uejima M; Morioka C; Komeda Y; Uemura M; Yoshiji H; Fukui H
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1701-6. PubMed ID: 16246189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial.
    Henderson JM; Kutner MH; Millikan WJ; Galambos JT; Riepe SP; Brooks WS; Bryan FC; Warren WD
    Ann Intern Med; 1990 Feb; 112(4):262-9. PubMed ID: 2404448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices.
    Al Traif I; Fachartz FS; Al Jumah A; Al Johani M; al-Omair A; al-Bakr F; al-Knawy B; el-Hafi A; Khan MH
    Gastrointest Endosc; 1999 Jul; 50(1):1-6. PubMed ID: 10385713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial.
    De BK; Ghoshal UC; Das T; Santra A; Biswas PK
    J Gastroenterol Hepatol; 1999 Mar; 14(3):220-4. PubMed ID: 10197489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study.
    Witzel L; Wolbergs E; Merki H
    Lancet; 1985 Apr; 1(8432):773-5. PubMed ID: 2858664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.
    Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K
    Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
    Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
    Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
    Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J
    Hepatogastroenterology; 1995; 42(6):979-84. PubMed ID: 8847055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.
    Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices.
    Chan AC; Chung SC; Sung JY; Leung JW; Li AK
    Endoscopy; 1993 Oct; 25(8):513-7. PubMed ID: 8287811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
    Stiegmann GV; Goff JS; Michaletz-Onody PA; Korula J; Lieberman D; Saeed ZA; Reveille RM; Sun JH; Lowenstein SR
    N Engl J Med; 1992 Jun; 326(23):1527-32. PubMed ID: 1579136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Band ligation or sclerotherapy as endoscopic treatment for oesophageal varices in schistosomotic patients: results of a randomized study.
    Siqueira ES; Rohr MR; Libera ED; Castro RR; Ferrari AP
    HPB Surg; 1998; 11(1):27-32. PubMed ID: 9830578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of variceal bleeding.
    Chen J; Zeng XQ; Ma LL; Li B; Tseng YJ; Lian JJ; Gao H; Wang J; Luo TC; Chen SY
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):95-100. PubMed ID: 26517621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial.
    Elsebaey MA; Tawfik MA; Ezzat S; Selim A; Elashry H; Abd-Elsalam S
    BMC Gastroenterol; 2019 Feb; 19(1):23. PubMed ID: 30717684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
    Dowidar N; Hafez A
    J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.